Global contract manufacturing organization, Orion Contract Manufacturing, has signed a commercial supply agreement with Peptonic Medical for the manufacture and packaging of its patented product, VagiVital.

The over-the-counter (OTC) product is used to treat vaginal atrophy and dryness and is due to launch later this year. Following the successful transfer of the product’s manufacturing technology, Orion Contract Manufacturing, based in Espoo, Finland, will be responsible for the launch and ongoing supply of the product to multiple markets.

“We have over a decade of experience working with gels and solutions similar to VagiVital. Our knowledge of manufacturing semi-solid products of this nature made us an ideal candidate for this project,” said Esa Nauska, head of Orion Contract Manufacturing. “Our versatility manufacturing and packaging expertise also mean that we can scale the formulation up to commercial production while meeting multiple market requirements. We’re looking forward to what will hopefully be a long and mutually beneficial partnership with Peptonic Medical.”

Johan Inborr, chief executive officer, Peptonic Medical, said, “Orion has met all our expectations during our collaboration so far ensuring successful technology transfer to enable the rest of the project. We have great confidence in its manufacturing and packaging capabilities and are excited to work together to bring our product to market. We’re very much looking forward to developing a long-lasting partnership with Orion.”

Orion Contract Manufacturing, based in Finland, is part of the Orion Corporation and specializes in the manufacture of finished dosage forms including hormonal gels and solutions, small volume parenterals, tablets, capsules, dry powder inhalers, creams, ointments and liquid formulations for the global pharmaceutical market. Orion has FDA/EMA/JP/ANVISA compliant facilities in Finland.